NasdaqCM - Delayed Quote • USD
Processa Pharmaceuticals, Inc. (PCSA)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 4:46 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.98 | -1.02 | -5.45 | -4.05 |
| Low Estimate | -0.98 | -1.02 | -7 | -6 |
| High Estimate | -0.98 | -1.02 | -3.9 | -2.11 |
| Year Ago EPS | -3.6 | -1.6 | -8.48 | -5.45 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -5.6 | -2 | -1.6 | -1.18 |
| EPS Actual | -3.6 | -1.6 | -1.7 | -1.11 |
| Difference | 2 | 0.4 | -0.1 | 0.07 |
| Surprise % | 35.70% | 20.00% | -6.20% | 5.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.98 | -1.02 | -5.45 | -4.05 |
| 7 Days Ago | -0.9 | -0.99 | -5.41 | -3.94 |
| 30 Days Ago | 0 | 0 | -7 | -6 |
| 60 Days Ago | 0 | 0 | -7 | -6 |
| 90 Days Ago | 0 | 0 | -7 | -6 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | PCSA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 72.80% | -- | -- | 8.00% |
| Next Qtr. | 36.30% | -- | -- | 12.40% |
| Current Year | 35.70% | -- | -- | 5.60% |
| Next Year | 25.70% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 11.14% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
| Initiated | HC Wainwright & Co.: Buy | 4/25/2024 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 3/6/2024 |
Related Tickers
CYCC Cyclacel Pharmaceuticals, Inc.
2.2900
-2.14%
PALI Palisade Bio, Inc.
6.36
-1.55%
APVO Aptevo Therapeutics Inc.
0.8000
+0.48%
PBLA Panbela Therapeutics, Inc.
0.4401
-8.31%
ALLR Allarity Therapeutics, Inc.
0.6390
-5.02%
SPRC SciSparc Ltd.
1.2200
+1.67%
TCBP TC Biopharm (Holdings) Plc
1.1300
-0.88%
ZVSA ZyVersa Therapeutics, Inc.
4.4872
-7.67%
ADIL Adial Pharmaceuticals, Inc.
1.5500
+9.93%
PBM Psyence Biomedical Ltd.
0.8698
-3.03%